Published in TB and Outbreaks Week, April 26th, 2011
"The sensitivity of the IGRAs QuantiFFRON ®-TB Gold (QFT-G) and T-SPOT ®.TB was evaluated among specimens from newly diagnosed adults with microbiologically confirmed TB with and without diabetes. We...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week